Cargando…
Nucleic acid-based therapeutics for the treatment of central nervous system disorders
Nucleic acid-based therapeutics (NBTs) are an emerging class of drugs with potential for the treatment of a wide range of central nervous system conditions. To date, pertaining to CNS indications, there are two commercially available NBTs and a large number of ongoing clinical trials. However, these...
Autores principales: | McCartan, Robyn, Khorkova, Olga, Volmar, Claude-Henry, Wahlestedt, Claes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468602/ https://www.ncbi.nlm.nih.gov/pubmed/37662844 http://dx.doi.org/10.3389/fgene.2023.1250276 |
Ejemplares similares
-
Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments
por: Khorkova, Olga, et al.
Publicado: (2021) -
Amplifying gene expression with RNA-targeted therapeutics
por: Khorkova, Olga, et al.
Publicado: (2023) -
Natural antisense transcripts as drug targets
por: Khorkova, Olga, et al.
Publicado: (2022) -
Involvement of long noncoding RNAs in diseases affecting the central nervous system
por: Pastori, Chiara, et al.
Publicado: (2012) -
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research
por: Dennison, Jessica L., et al.
Publicado: (2021)